Barankiewicz, J.; Szumera-Ciećkiewicz, A.; Salomon-Perzyński, A.; Wieszczy, P.; Malenda, A.; Garbicz, F.; Prochorec-Sobieszek, M.; Misiewicz-Krzemińska, I.; Juszczyński, P.; Lech-Marańda, E.
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients. J. Clin. Med. 2021, 10, 2683.
https://doi.org/10.3390/jcm10122683
AMA Style
Barankiewicz J, Szumera-Ciećkiewicz A, Salomon-Perzyński A, Wieszczy P, Malenda A, Garbicz F, Prochorec-Sobieszek M, Misiewicz-Krzemińska I, Juszczyński P, Lech-Marańda E.
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients. Journal of Clinical Medicine. 2021; 10(12):2683.
https://doi.org/10.3390/jcm10122683
Chicago/Turabian Style
Barankiewicz, Joanna, Anna Szumera-Ciećkiewicz, Aleksander Salomon-Perzyński, Paulina Wieszczy, Agata Malenda, Filip Garbicz, Monika Prochorec-Sobieszek, Irena Misiewicz-Krzemińska, Przemysław Juszczyński, and Ewa Lech-Marańda.
2021. "The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients" Journal of Clinical Medicine 10, no. 12: 2683.
https://doi.org/10.3390/jcm10122683
APA Style
Barankiewicz, J., Szumera-Ciećkiewicz, A., Salomon-Perzyński, A., Wieszczy, P., Malenda, A., Garbicz, F., Prochorec-Sobieszek, M., Misiewicz-Krzemińska, I., Juszczyński, P., & Lech-Marańda, E.
(2021). The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients. Journal of Clinical Medicine, 10(12), 2683.
https://doi.org/10.3390/jcm10122683
